This page is part of the FHIR Specification (v1.2.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4B R4 R3
This is the narrative for the resource. See also the XML or JSON format. This example conforms to the profile Observation for Genetics (FHIR Specification Core)).
Generated Narrative with Details
id: ob-genetics-1
status: final
code: Genetic analysis master panel (Details : {LOINC code '55233-1' = 'Genetic analysis master panel - Blood or Tissue by Molecular genetics method', given as 'Genetic analysis master panel'})
subject: Molecular Lab Patient ID: HOSP-23456
issued: 11/03/2013 10:28:00 AM
performer: Molecular Diagnostic Laboratory
value: Positive (Details : {SNOMED CT code '10828004' = '10828004', given as 'Positive'})
specimen: Molecular Specimen ID: MLD45-Z4-1234
component
code: Genetic disease assessed (Details : {LOINC code '51967-8' = 'Genetic disease assessed [Identifier] in Blood or Tissue by Molecular genetics method', given as 'Genetic disease assessed'})
value: Lung cancer (Details : {SNOMED CT code '363358000' = '??', given as 'Malignant tumor of lung (disorder)'})
component
code: Genetic disease sequence variation interpretation (Details : {LOINC code '53037-8' = 'Genetic disease sequence variation interpretation [interpretation] in Blood or Tissue by Molecular genetics method', given as 'Genetic disease sequence variation interpretation'})
value: Pathogenic (Details : {[not stated] code 'LA6669-1' = '??', given as 'Pathogenic'})
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.